News summary
[North China Pharmaceuticalminecryptogame: The wholly-owned subsidiary passed drug GMP compliance inspection] Securities Times e Company Newsminecryptogame, North China Pharmaceutical (600812) announced on the evening of May 22 that its wholly-owned subsidiary Xiantai Company had received the "Drug GMP Compliance Inspection Notice" issued by the Drug Administration of Hebei Province. This drugminecryptogame.minecryptogame..
Newsletter text
[North China Pharmaceutical: The wholly-owned subsidiary passed the GMP compliance inspection] Securities Times e Company News, North China Pharmaceutical (600812) announced on the evening of May 22 that its wholly-owned subsidiary Xiantai Company received the "Notice on GMP Compliance Inspection" issued by the Drug Administration of Hebei Province. This drug GMP compliance inspection is the first drug GMP compliance inspection before being marketed after ampicillin (enzymatic method) and piperacillin were registered and approved. It is a new product added to the original product production line, and the production equipment and facilities of this workshop have not changed or added investment.